相关实验视频
Updated: Jan 13, 2026

09:44
Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
Published on: January 25, 2016
19.7K
多药和自我报告的听力障碍之间的关联:使用ATC分类和HHIE-S-It问卷的观察性研究
Francesco Martines1, Pietro Salvago1, Gianluca Lavanco2
1Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), Section of Audiology, University of Palermo, Via del Vespro, 129-90127 Palermo, Italy.
Audiology research
|October 28, 2025
概括
服用多种药物会增加听力损失的风险,某些药物类别的风险更高. 抗糖尿病药物可能会对听力障碍产生保护作用.
科学领域:
- 听力学 听力学是指听力学.
- 药理学 药理学 是一个学科.
- 公共卫生 公共卫生
背景情况:
- 听力损失是一个重要的全球健康问题,特别是在成年期.
- 它可以由潜在的病理和多药性 (同时使用多种药物) 加剧.
研究的目的:
- 调查药物使用和自我报告的听力损失之间的关联,在多样化的患者队列中.
- 探索多药学,特定药物类别和听力障碍之间的关系.
主要方法:
- 一项观察性研究涉及1651名患者 (18至99岁) 具有详细的病理和药理资料.
- 使用HHIE-S-It问卷进行了自我报告听力损失的评估.
- 药物分类使用了解剖治疗分类 (ATC) 系统.
主要成果:
- 与非药物使用者相比,接受单一或多重疗法的患者表现出更大的听力缺陷.
- 观察到一种剂量反应关系:增加药物计数与中度至重度听力损失的风险更高相关.
- 心血管和与酸相关的疾病药物与增加听力损伤风险有关;抗糖尿病药物显示有保护作用.
结论:
- 药物的数量和特定类型都会影响感知到的听力障碍.
- 听力学评估应纳入多药房管理.
- 这些发现支持开发更安全,个性化的治疗策略.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
248
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
248
Drug Dosing: Geriatric Patients
219
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
219
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K

